Aspira Women's Health Inc. (AWHL) stock
AWHLOTCIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$0.22−0.01 (-2.61%)
Close on Oct 19, 2026Market cap $9.91MP/E –Yield –
Aspira Women's Health profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Aspira Women's Health's profit margin for the twelve months ending Jun 30, 2026 was -5885.3%. For fiscal 2025 it was -3725.9%, against -327350.0% the year before. The highest annual figure on record is -19.2% in fiscal 2023.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -3725.9% | +323624.1 |
| FY2024 | Dec 31, 2024 | -327350.0% | −327330.8 |
| FY2023 | Dec 31, 2023 | -19.2% | +346.0 |
| FY2022 | Dec 31, 2022 | -365.2% | +99.6 |
| FY2021 | Dec 31, 2021 | -464.8% | −79.8 |
| FY2020 | Dec 31, 2020 | -385.0% | −49.2 |
| FY2019 | Dec 31, 2019 | -335.8% | +36.7 |
| FY2018 | Dec 31, 2018 | -372.5% | −36.1 |
| FY2017 | Dec 31, 2017 | -336.3% | +230.2 |
| FY2016 | Dec 31, 2016 | -566.5% | +311.5 |
| FY2015 | Dec 31, 2015 | -878.0% | −116.1 |
| FY2014 | Dec 31, 2014 | -762.0% | −418.3 |
| FY2013 | Dec 31, 2013 | -343.7% | −2.4 |
| FY2012 | Dec 31, 2012 | -341.3% | +583.9 |
| FY2011 | Dec 31, 2011 | -925.1% | +694.8 |
| FY2010 | Dec 31, 2010 | -1619.9% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -14235.3% | −12657.8 |
| Q1 FY2026 | Mar 31, 2026 | 2112.5% | +2269.7 |
| Q4 FY2025 | Dec 31, 2025 | -10528.1% | −10382.4 |
| Q3 FY2025 | Sep 30, 2025 | -5496.6% | −5281.6 |
| Q2 FY2025 | Jun 30, 2025 | -1577.5% | −1573.7 |
| Q3 FY2024 | Sep 30, 2024 | -157.2% | +55.1 |
| Q2 FY2024 | Jun 30, 2024 | -145.7% | −52.7 |
| Q1 FY2024 | Mar 31, 2024 | -215.0% | +69.0 |
| Q4 FY2023 | Dec 31, 2023 | -3.9% | +209.4 |
| Q3 FY2023 | Sep 30, 2023 | -212.3% | +163.4 |
| Q2 FY2023 | Jun 30, 2023 | -93.0% | +306.0 |
| Q1 FY2023 | Mar 31, 2023 | -284.0% | +205.6 |
| Q4 FY2022 | Dec 31, 2022 | -213.2% | +270.9 |
| Q3 FY2022 | Sep 30, 2022 | -375.6% | +207.0 |
| Q2 FY2022 | Jun 30, 2022 | -399.0% | −5.8 |
| Q1 FY2022 | Mar 31, 2022 | -489.6% | −93.9 |
| Q4 FY2021 | Dec 31, 2021 | -484.1% | −63.6 |
| Q3 FY2021 | Sep 30, 2021 | -582.7% | −236.6 |
| Q2 FY2021 | Jun 30, 2021 | -393.2% | +120.3 |
| Q1 FY2021 | Mar 31, 2021 | -395.7% | −92.0 |
| Q4 FY2020 | Dec 31, 2020 | -420.5% | −161.6 |
| Q3 FY2020 | Sep 30, 2020 | -346.0% | −48.7 |
| Q2 FY2020 | Jun 30, 2020 | -513.5% | −135.8 |
| Q1 FY2020 | Mar 31, 2020 | -303.8% | +159.0 |
| Q4 FY2019 | Dec 31, 2019 | -258.9% | +46.9 |
| Q3 FY2019 | Sep 30, 2019 | -297.3% | +45.4 |
| Q2 FY2019 | Jun 30, 2019 | -377.8% | +52.9 |
| Q1 FY2019 | Mar 31, 2019 | -462.8% | −23.6 |
| Q4 FY2018 | Dec 31, 2018 | -305.9% | +64.4 |
| Q3 FY2018 | Sep 30, 2018 | -342.6% | +16.3 |
| Q2 FY2018 | Jun 30, 2018 | -430.6% | −167.8 |
| Q1 FY2018 | Mar 31, 2018 | -439.1% | −71.0 |
| Q4 FY2017 | Dec 31, 2017 | -370.3% | −16.8 |
| Q3 FY2017 | Sep 30, 2017 | -358.9% | +199.0 |
| Q2 FY2017 | Jun 30, 2017 | -262.8% | – |
| Q1 FY2017 | Mar 31, 2017 | -368.2% | – |
| Q4 FY2016 | Dec 31, 2016 | -353.5% | – |
| Q3 FY2016 | Sep 30, 2016 | -557.9% | – |
See a number that looks wrong?